Peggy GANDIA

Présentation

Publications

Article dans une revue (61)

Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD Sahira Chaiben,Peggy Gandia,Thibaut Jamme,Nicolas Congy,Didier Concordet CPT: Pharmacometrics and Systems Pharmacology, 2026, 15 (1), pp.e70152. ⟨10.1002/psp4.70152⟩ Article dans une revue hal-05565148v1
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study Nadège Néant,Minh Lê,Stéphane Bouchet,Jennifer Lagoutte-Renosi,Matthieu Grégoireet al. Clinical Infectious Diseases, 2025, pp.ciaf385. ⟨10.1093/cid/ciaf385⟩ Article dans une revue hal-05240572v1
Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblance Peggy Gandia,Sahira Chaiben,Nicolas Fabre,Didier Concordet CPT: Pharmacometrics and Systems Pharmacology, In press, 14 (1), pp.142-151. ⟨10.1002/psp4.13253⟩ Article dans une revue hal-04817060v1
Multidimensional reference regions is a new tool to optimize the personalized care of patients Peggy Gandia,Angélo Faget,Thibaut Jamme,Jérôme Ausseil,Didier Concordet Scientific Reports, 2025, 15 (1), pp.25189. ⟨10.1038/s41598-025-10173-0⟩ Article dans une revue hal-05161766v1
Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic model Midas B Mulder,Martijn van Noort,Robert A de Man,Nassim Kamar,Joep de Bruijneet al. Journal of Antimicrobial Chemotherapy, 2025, 80 (8), pp.2158-2168. ⟨10.1093/jac/dkaf183⟩ Article dans une revue hal-05523280v1
JC Virus–Related Retinopathy Fanny Varenne,Aurore Siegfried-Vergnon,Sébastien Lhomme,Emmanuel Treiner,Béatrice Pignoletet al. JAMA Ophthalmology, 2025, 143 (9), pp.785. ⟨10.1001/jamaophthalmol.2025.2235⟩ Article dans une revue hal-05514391v1
A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project Anaëlle Monfort,Evelina Cardoso,Chin B Eap,Nicolas Ansermot,Severine Crettolet al. British Journal of Clinical Pharmacology, 2024, 90 (11), pp.2849-2860. ⟨10.1111/bcp.16177⟩ Article dans une revue hal-04662844v1
Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project Hedvig Nordeng,Christine Wegler,Annika Lindqvist,Erik Melander,Mikaela Magnussonet al. Basic and Clinical Pharmacology and Toxicology, 2023, 134 (1), pp.153-164. ⟨10.1111/bcpt.13948⟩ Article dans une revue hal-04948333v1
Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades Peggy Gandia,Sarah Decheiver,Manon Picard,Romain Guilhaumou,Sarah Bakloutiet al. Antibiotics, 2023, 12 (3), pp.515. ⟨10.3390/antibiotics12030515⟩ Article dans une revue hal-04061765v1
Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis Justine Madaule,Félix Valenzuela,Marie Mittaine,Yohan Gallois,Blandine Baladiet al. Journal of Cystic Fibrosis, 2023, 22 (5), pp.944-948. ⟨10.1016/j.jcf.2023.04.002⟩ Article dans une revue hal-04086358v1
“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring Sarah Baklouti,Peggy Gandia,Didier Concordet Clinical Pharmacokinetics, 2022, 61 (5), pp.749 - 757. ⟨10.1007/s40262-021-01105-y⟩ Article dans une revue hal-03670618v1
Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model? Sarah Baklouti,S. Marolleau,P. Chavanet,E. Bonnet,Didier Concordetet al. Antimicrobial Agents and Chemotherapy, 2022, 66 (1), ⟨10.1128/AAC.01493-21⟩ Article dans une revue hal-03578727v1
Maraviroc exposure is influenced by exogenous thyrotoxicosis David Metsu,Christian Aquilina,Pierre Delobel,Peggy Gandia,Frédérique Savagneret al. AIDS. Official journal of the international AIDS Society, 2021, 35 (4), pp.701-703. ⟨10.1097/QAD.0000000000002754⟩ Article dans une revue hal-03473015v1
Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age : A Retrospective Monocentric Cohort Study Stella Rousset,Margaux Lafaurie,Hélène Guet-Revillet,Caroline Protin,Jean Le Grusseet al. Drugs and Aging, 2021, 38 (1), pp.43-52. ⟨10.1007/s40266-020-00811-9⟩ Article dans une revue hal-03158686v1
Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection Midas B Mulder,Robert A Man,Nassim Kamar,Gűlcan Durmaz,Joep Bruijneet al. Journal of Viral Hepatitis, 2021, 28 (2), pp.431-435. ⟨10.1111/jvh.13432⟩ Article dans une revue hal-03580025v1
Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation Arnaud del Bello,Clotilde Gaible,Nathalie Longlune,Anne-Laure Hebral,Lauren Espositoet al. Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.602764⟩ Article dans une revue hal-03623073v1
Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure Francoise Stanke-Labesque,Didier Concordet,Zoubir Djerada,Stephane Bouchet,Caroline Solaset al. Clinical Pharmacology and Therapeutics, 2021, Therapeutic Innovations in Infectious Diseases, 109 (4), pp.1030-1033. ⟨10.1002/cpt.2196⟩ Article dans une revue hal-03191652v1
Efficacy of dihydroartemisinin/piperaquine in patients with noncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon Mélissa Mairet-Khedim,Sandrine Nsango,Christelle Ngou,Sandie Menard,Camille Roeschet al. Journal of Antimicrobial Chemotherapy, 2021, 76 (11), pp.3037-3044. ⟨10.1093/jac/dkab281⟩ Article dans une revue pasteur-03494748v1
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00812-x⟩ Article dans une revue hal-02624662v1
Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations Eloise Baudou,Anne Lespine,Geneviève Durrieu,François André,Peggy Gandiaet al. New England Journal of Medicine, 2020, 383 (8), pp.787--789. ⟨10.1056/NEJMc1917344⟩ Article dans une revue hal-02928174v1
Authors' Reply to Yu et al.: &quot;&quot;Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00852-3⟩ Article dans une revue hal-02619187v1
Authors' Reply to Krebs-Brown et al. Comment on: &quot;Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One? Didier Concordet,Peggy Gandia,J L Montastruc,Alain Bousquet‐mélou,P Leeset al. Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00848-z⟩ Article dans une revue hal-02627432v1
Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study Camille Mané,Clément Delmas,Jean Porterie,Géraldine Jourdan,Patrick Verwaerdeet al. Journal of Translational Medicine, 2020, 18 (1), pp.213. ⟨10.1186/s12967-020-02381-1⟩ Article dans une revue hal-02940915v1
Authors' Reply to Nicolas: &quot;Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00851-4⟩ Article dans une revue hal-02627433v1
Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach David Metsu,Thomas Lanot,François Fraissinet,Didier Concordet,Véronique V. Gayrard-Troyet al. Scientific Reports, 2020, 10 (1), ⟨10.1038/s41598-020-69102-y⟩ Article dans une revue hal-02911804v1
Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics Guillaume Martin-Blondel,Stéphanie Ruiz,Marlene Murris,Stanilas Faguer,Véronigue Duhaldeet al. Clinical Infectious Diseases, 2020, 71 (11), pp.2962-2964. ⟨10.1093/cid/ciaa558⟩ Article dans une revue hal-03167732v1
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients Sarah Baklouti,Clémence Massip,Camille Mane,Hélène Guet-Revillet,Marlene Murriset al. Journal of Antimicrobial Chemotherapy, 2019, 74 (10), pp.3122-3123. ⟨10.1093/jac/dkz307⟩ Article dans une revue hal-02625024v1
Suicide Attempts Juliette Salles,Bernard Tiret,Adeline Gallini,Peggy Gandia,Christophe Arbuset al. Suicide and Life-Threatening Behavior, 2019, 50 (1), pp.315-328. ⟨10.1111/sltb.12586⟩ Article dans une revue hal-03464218v1
Authors' Reply to Lechat et al.: &quot; New and Old Formulations: Are they Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2019, 58 (10), pp.1353-1354. ⟨10.1007/s40262-019-00815-8⟩ Article dans une revue hal-02619071v1
Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR) Romain Guilhaumou,Sihem Benaboud,Youssef Bennis,Claire Dahyot-Fizelier,Eric Daillyet al. Critical Care, 2019, 23, pp.104. ⟨10.1186/s13054-019-2378-9⟩ Article dans une revue hal-02095159v1
Authors' Reply to Coste et al.:&quot;Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2019, 58 (7), pp.967-968. ⟨10.1007/s40262-019-00780-2⟩ Article dans une revue hal-02623560v1
Authors'Reply to Castello-Bridoux et al.:&quot;Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2019, 58 (7), pp.973-975. ⟨10.1007/s40262-019-00786-w⟩ Article dans une revue hal-02627694v1
Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, In press, 58 (7), pp.827-833. ⟨10.1007/s40262-019-00747-3⟩ Article dans une revue hal-02095017v1
Author's Reply to Trechot: &quot;Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2019, 58 (7), pp.979-980. ⟨10.1007/s40262-019-00787-9⟩ Article dans une revue hal-02619069v1
Pourquoi, comment et où dose-t-on les antihypertenseurs en 2019 ? Beatrice Bouhanick,Pauline Fonquernie,India Bedue,Anaïs Schavgoulidze,Peggy Gandia Thérapie, 2019, 74 (6), pp.651-664. ⟨10.1016/j.therap.2019.05.002⟩ Article dans une revue hal-02624869v1
HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy Claire Guerveno,Stéphanie Raymond,David Metsu,Peggy Gandia,Jacques Izopetet al. AIDS. Official journal of the international AIDS Society, 2019, 33 (3), pp.593-594. ⟨10.1097/QAD.0000000000002089⟩ Article dans une revue hal-02618284v1
Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach Théo Willeman,Julia Tonini,Cécile Garnaud,Sébastien Bailly,Peggy Gandiaet al. Fundamental & Clinical Pharmacology, 2019, ⟨10.1111/fcp.12507⟩ Article dans une revue hal-02976876v1
Memory impairment following intentional self-poisoning with benzodiazepines Juliette Salles,Jérémie Pariente,Laurent Schmitt,Dominique Lauque,Thomas Lanotet al. Journal of Psychopharmacology, 2019, 33 (11), pp.1428-1435. ⟨10.1177/0269881119867609⟩ Article dans une revue hal-03641012v1
Authors' Reply to Nicolas:&quot;New and Old Formulations: Are they Switchable for Millions of Patients? Didier Concordet,Peggy Gandia,Jean-Louis Montastruc,Alain Bousquet‐mélou,Peter Leeset al. Clinical Pharmacokinetics, 2019, 58 (7), pp.961-963. ⟨10.1007/s40262-019-00781-1⟩ Article dans une revue hal-02620199v1
Dosage des médicaments antihypertenseurs en France en 2019 et observance. Beatrice Bouhanick,Bernard Vaïsse,Anaïs Schavgoulidze,Peggy Gandia La Presse Médicale, 2019, 48 (12), pp.1520-1526. ⟨10.1016/j.lpm.2019.08.009⟩ Article dans une revue hal-02624854v1
Isavuconazole Kinetic Exploration for Clinical Practice. Léa Darnaud,Fabien Lamoureux,Cendrine Godet,Sandrine Pontier,Alexia Debardet al. Drugs in R&D, 2018, 18 (4), pp.317-321. ⟨10.1007/s40268-018-0251-y⟩ Article dans une revue hal-02628582v1
Efavirenz and lopinavir levels in HIV-infected women and their nursing infants, in Mali Aboubacar Alassane Oumar,Kadiatou Bagayoko-Maiga,Aliou Bahachimi,Mamoudou Maiga,Marie-Christine Cereet al. Journal of Pharmacology and Experimental Therapeutics, 2018, 366 (3), pp.479-484. ⟨10.1124/jpet.118.249938⟩ Article dans une revue hal-02625041v1
Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods David Metsu,Thomas Lanot,François Fraissinet,Mélanie Picot,Didier Concordetet al. Clinica Chimica Acta, 2018, 479, pp.56-65. ⟨10.1016/j.cca.2017.12.034⟩ Article dans une revue hal-02621511v1
Population pharmacokinetics of tracers: A new tool for medical imaging? Peggy Gandia,Cyril Jaudet,Etienne Chatelut,Didier Concordet Clinical Pharmacokinetics, 2017, 56 (2), pp.101-106. ⟨10.1007/s40262-016-0437-9⟩ Article dans une revue hal-01607048v1
Pharmacokinetics of teicoplanin in a breastfeeding mother François Fraissinet,Marine Lesourd,Nicolas Naudoux,David Metsu,Peggy Gandia Breastfeeding Medicine, 2017, 12 (4), pp.244-246. ⟨10.1089/bfm.2017.0016⟩ Article dans une revue hal-01600682v1
Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring? David Metsu,Patrick Séraissol,Pierre Delobel,Christel Cinq-Frais,Lise Cuzinet al. Fundamental & Clinical Pharmacology, 2017, ⟨10.1111/fcp.12245⟩ Article dans une revue hal-01907438v1
Population pharmacokinetic approach applied to positron emission tomography: Computed tomography for tumor tissue identification in patients with glioma Peggy Gandia,Cyril Jaudet,Hendrik Everaert,Johannes Heemskerk,Anne Marie Vanbinstet al. Clinical Pharmacokinetics, 2017, 56 (8), pp.953-961. ⟨10.1007/s40262-016-0490-4⟩ Article dans une revue hal-01601882v1
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle? David Metsu,Pierre-Louis Toutain,Etienne Chatelut,Pierre Delobel,Peggy Gandia Journal of Antimicrobial Chemotherapy, 2017, 72 (9), pp.2407-2409. ⟨10.1093/jac/dkx176⟩ Article dans une revue hal-01608734v1
Quinine unbound concentration is the best marker for therapeutic drug monitoring. Carlos de Pablos-Martinez,Lydie Porte,François Fraissinet,Antoine Berry,Patrick Séraissolet al. Thérapie, 2016, 71 (5), pp.487-489. ⟨10.1016/j.therap.2016.02.032⟩ Article dans une revue hal-01601653v1
Quinine unbound concentration has to be used for therapeutic drug monitoring. Carlos de Pablos-Martinez,Lydie Porte,François Fraissinet,Antoine Berry,Patrick Séraissolet al. Therapeutic Drug Monitoring, 2016, 38 (4), pp.556-7. ⟨10.1097/FTD.0000000000000304⟩ Article dans une revue hal-02634648v1
Problèmes et difficultés rencontrés lors de la planification et de l'analyse d'un essai de bioéquivalence. Pierre-Louis Toutain,Peggy Gandia,Alain Bousquet‐mélou La Lettre du Pharmacologue, 2014, 28 (2), pp.37-50 Article dans une revue hal-02630493v1
Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships. Aurélie Prémaud,Annick Rousseau,Gyasi Johnson,Cindy Canivet,Peggy Gandiaet al. Pharmacological Research, 2011, 63 (5), pp.432-8. ⟨10.1016/j.phrs.2011.01.005⟩ Article dans une revue istex inserm-00926481v1
Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome. Franck Saint-Marcoux,V. Guigonis,S. Decramer,P. Gandia,B. Ranchinet al. Pharmacological Research, 2011, 63 (5), pp.423-31. ⟨10.1016/j.phrs.2011.01.009⟩ Article dans une revue istex inserm-00926458v1
Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation Stéphane Firmin,Peggy Gandia,Diego Morgavi,Georges Houin,Jp Jouanyet al. Food Additives and Contaminants, 2010, 27 (08), pp.1153-1160. ⟨10.1080/19440041003801174⟩ Article dans une revue hal-00604043v1
Clomipramine in breast milk: a case study D Khachman,Peggy Gandia,Ma Gaillard,P Seraissol,P Mendousseet al. Journal de Pharmacie Clinique, 2009, pp.33-38 Article dans une revue hal-02654422v1
Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome. Cindy Canivet,Lionel Rostaing,Sylvain Galvani,Torsten Böhler,Peggy Gandiaet al. International Immunopharmacology, 2009, 9 (9), pp.1131-6. ⟨10.1016/j.intimp.2009.05.004⟩ Article dans une revue istex inserm-00410375v1
Immediate and delayed hypersensitivity reactions to iodinated radiographic contrast agents: an update. D. Khachman,Peggy Gandia,Francois Sallerin,Nicolas Mailly Thérapie, 2009, pp.331-339. ⟨10.2515/therapie/2009040⟩ Article dans une revue istex hal-02665979v1
Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome Cindy Canivet,Lionel Rostaing,Sylvain Galvani,Torsten Böhler,Peggy Gandiaet al. International Immunopharmacology, 2009, 9 (9), pp.1131-1136. ⟨10.1016/j.intimp.2009.05.004⟩ Article dans une revue istex hal-02352459v1
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nassim Kamar,Isabelle Gennero,Luciana Spataru,Laure Esposito,Joelle Guitardet al. Nephrology Dialysis Transplantation, 2008, 23 (11), pp.3720-6. ⟨10.1093/ndt/gfn345⟩ Article dans une revue istex inserm-00409076v1
Transfer of benzodiazepines into breast milk: clinical and analytical aspects D Khachman,Peggy Gandia,F Sena,C Tortissier,P Seraissolet al. Annales de Toxicologie Analytique, 2008, pp.165-179 Article dans une revue hal-02661242v1
Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter. Guylène Lafforgue,Cécile Arellano,Christelle Vachoux,John Woodley,Claude Philibertet al. Fundamental & Clinical Pharmacology, 2008, 22 (2), pp.189-201. ⟨10.1111/j.1472-8206.2008.00572.x⟩ Article dans une revue istex hal-00517537v1

Communication dans un congrès (1)

Exploring of primary brains tumor heterogeneity at a voxel level with dynamic 18F-fluoro-ethyl-tyrosine (18F-FET) positon emission tomography Cyril Jaudet,Peggy Gandia,Henrik Everaert,Rémi Servien,J.W. Heemskerket al. Congress of the Radiological Sociey of North-America (RSNA), Nov 2015, Chicago, United States. pp.NM219-SD-TUA8 Communication dans un congrès hal-03277832v1

Poster de conférence (5)

Unexpected low plasma levels of posaconazole with the gastro-resistant tablet: influence of pre-analytical conditions C Mane,L Darnaud,Didier Concordet,Peggy Gandia Annual Meeting of French Society of Pharmacology and Therapeutics and INSERM Clinical Research Centers Meeting ; Toulouse (France) - (2018-06-12 - 2018-06-14) / Rencontres, Jun 2018, Toulouse, France. Fundamental and Clinical Pharmacology, 32, 2018 Poster de conférence hal-02734860v1
Pharmacokinetic-Pharmacogenetic exploration of patients presenting unexpected high levels of isavuconazole L. Darnaud,F. Lamoureux,C. Godet,S. Pontier,A. Debardet al. Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, Jun 2018, Toulouse, France. Wiley-Blackwell, Fundamental and Clinical Pharmacology, 32, pp.1, 2018, Special Issue: Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting Poster de conférence hal-02734081v1
Intoxication with baclofen: is haemodialysis indicated? P. Gandia,S. Girod-Fullana,P. L. Toutain,E. Bertrand,Didier Concordetet al. Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, Jun 2018, Toulouse, France. Wiley-Blackwell, Fundamental and Clinical Pharmacology, 32, 2018, Special Issue: Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting Poster de conférence hal-02734668v1
Influence of ribavirin plasma concentration on the virological response and safety in patients with HCV genotype 1 infection treated by combination therapy with telaprevir or boceprevir Marie Julia,Peggy Gandia,Mathieu Guivarch,Laura Coimet-Berger,Florence Abravanelet al. The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2014, Nov 2014, Boston, United States. Poster de conférence hal-03266134v1
Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats by a yeast cell wall preparation Stéphane Firmin,P. Gandia,Diego Morgavi,J Pierre Jouany,G. Houinet al. World Mycotoxin Reduction in Food and Feed Chains, Sep 2009, Tulln, Australia. 2009 Poster de conférence hal-02758381v1

Chapitre d'ouvrage (2)

Etudes pharmacocinétiques durant le développement clinique d'un médicament E. Chatelut,P. Gandia Pharmacocinétique: les fondamentaux, EDIMARK SAS, 2018, 978-2-915968-56-9 Chapitre d'ouvrage hal-02786282v1
Essais Cliniques de phase 1 E. Chatelut,P. Gandia Pharmacocinétique: les fondamentaux, EDIMARK SAS, 2018, 978-2-915968-56-9 Chapitre d'ouvrage hal-02786293v1

Cours (5)

ANTIHYPERTENSEURS - MODELISATION PK/PD Peggy Gandia Master. France. 2022 Cours hal-03854659v1
TOXICITE des AMINOSIDES - MODELISATION PK/PD Peggy Gandia Master. France. 2022 Cours hal-03853461v1
ANESTHESIE GENERALE - MODELISATION PK/PD Peggy Gandia Master. France. 2022 Cours hal-03853444v1
ANTIBIOTIQUES et EFFICACITE MICROBIOLOGIQUE Peggy Gandia Master. France. 2022 Cours hal-03853511v1
CONCEPTS FONDAMENTAUX en MODELISATION PHARMACOCINETIQUE-PHARMACODYNAMIQUE Peggy Gandia Master. France. 2022 Cours hal-03848538v1